Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GHSR | Q92847 | 7/20 | 0.65 |
| ▸ | NPY1R | P25929 | 3/20 | 0.60 |
| ▸ | NPY2R | P49146 | 3/20 | 0.60 |
| ▸ | NPY4R | P50391 | 3/20 | 0.60 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.57 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.56 |
| ▸ | MC4R | P32245 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29641067 | 1.00 | GHSR (0.65) | GHSRNPY1RNPY2RNPY4RKISS1R | |
| SCHEMBL29641033 | 1.00 | GHSR (0.65) | GHSRNPY1RNPY2RNPY4RKISS1R | |
| SCHEMBL29641169 | 1.00 | GHSR (0.65) | GHSRNPY1RNPY2RNPY4RKISS1R | |
| SCHEMBL29641171 | 0.98 | GHSR (0.68) | GHSR | |
| SCHEMBL29672136 | 0.96 | NPY4R (0.62) | GHSRNPY1RNPY2RNPY4RKISS1R | |
| SCHEMBL29641180 | 0.96 | GHSR (0.58) | GHSRNPY1RNPY2RNPY4RUTS2R | |
| SCHEMBL30118086 | 0.95 | GHSR (0.57) | GHSRNPY1RNPY2RNPY4RUTS2R | |
| SCHEMBL30773914 | 0.95 | GHSR (0.57) | GHSRNPY1RNPY2RNPY4RUTS2R | |
| SCHEMBL29419958 | 0.95 | GHSR (0.61) | GHSRNPY1RNPY2RNPY4R | |
| SCHEMBL22133204 | 0.94 | NPY1R (0.59) | GHSRNPY1RNPY2RNPY4RKISS1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4362988-B1 | ANTIMICROBIAL PEPTIDES AND THEIR USE | UNIV MANCHESTER (GB) | 2025-06-25 | — | — | EP | disclosed |
| US-20240299591-A1 | Antimicrobial Peptides and Their Use | THE UNIVERSITY OF MANCHESTER (GB) | 2024-09-12 | — | — | US | disclosed |
| EP-4362988-A1 | ANTIMICROBIAL PEPTIDES AND THEIR USE | The University of Manchester (GB) | 2024-05-08 | — | — | EP | disclosed |
| WO-2023275537-A1 | ANTIMICROBIAL PEPTIDES AND THEIR USE | THE UNIVERSITY OF MANCHESTER (GB) | 2023-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240299591-A1 | Antimicrobial Peptides and Their Use | VIP, FPR1, FPR2 | GHSR 1588/4885NPY1R 436/4885NPY2R 580/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.